IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Merial Limited v Intervet International [2017] APO 47
Patent Application: 2006289102
Title:PCV-2 vaccine
Patent Applicant: Intervet International B.V.
Opponent: Merial Limited
Delegate: Dr B. Akhurst
Decision Date: 19 September 2017
Hearing Date: 23 August 2017, in Canberra.
Catchwords: PATENTS – section 104 opposition - the claims as proposed to be amended fall within the scope of the accepted omnibus claim – any deficiencies under s102(2) do not arise as a result of the amendment – opposition unsuccessful.
Representation: Patent attorney for the applicant: David Myers.
Counsel for the opponent: Christian Dimitriadis and Claire Cunliffe.
Patent attorney for the opponent: Dr Jenny Petering of FB Rice.
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2006289102
Title:PCV-2 vaccine
Patent Applicant: Intervet International B.V.
Date of Decision: 19 September 2017
DECISION
The opposition is unsuccessful.
Costs are awarded according to Schedule 8 against Merial Limited.
At the hearing, I allowed Merial’s request on 9 August 2017 to amend its Statement of Grounds and Particulars.
REASONS FOR DECISION
Background
Patent application 2006289102 was filed by Intervet International B.V. (Intervet) on 8 September 2006. An opposition to grant of a patent by Merial Limited (Merial) was heard and the decision reported as Merial Limited v Intervet International B.V. [2016] APO 39 on 27 June 2016. That decision found that certain claims of the specification lacked an inventive step.
Intervet proposed amendments to the specification under section 104 on 23 August 2016 and after an adverse examination report, proposed further amendments on 27 October 2016. After the grant of leave to amend was advertised on 5 January 2017, Merial opposed allowance of the amendments. No party sought to file evidence and the matter was heard on 23 August 2017 in Canberra. The parties’ summaries of submissions for the hearing were filed on 9 August 2017 and 16 August 2017.
The Law
The request for examination of the patent application was filed before 15 April 2013 and as a consequence the substantive amendments of the Patents Act 1990 (the Act) brought about by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 do not apply to the present application. Instead, the relevant provisions of the Act in this matter is subsection 102(2) as it existed prior to the introduction of the ‘Raising the Bar’ Act, which are set out below:
(1) An amendment of a complete specification is not allowable if, as a result of the amendment, the specification would claim matter not in substance disclosed in the specification as filed.
(2)An amendment of a complete specification is not allowable after the relevant time if, as a result of the amendment:
(a)a claim of the specification would not in substance fall within the scope of the claims of the specification before amendment; or
(b) the specification would not comply with subsection 40(2) or (3).
The ‘relevant time’ for the purpose of s 102(2) is after the specification has been accepted[1]. Subsections 40(2) and 40(3) of the…
Keep reading for free
Create a free CaseChat account to read Merial Limited v Intervet International and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2017] APO 47
- Decision Date
CaseChat Overview and Summary
The key legal issue in this case was whether the proposed amendments to the claims of the patent application complied with the allowability criteria set out in subsection 102(2) of the Patents Act 1990. The Delegate found that the proposed amendments did not introduce any new subject matter beyond the scope of the accepted omnibus claim and that any deficiencies in the proposed claims did not arise as a result of the amendment. The Delegate relied on the principle that the application of s102 involves a two-stage process, where the first stage is to identify precisely what is the amendment, and the second stage is to determine whether the amendment results in the specification failing to comply with the allowability criteria set out in subsection 102(2). The Delegate found that the proposed amendments did not result in any failure to comply with the allowability criteria.
The Delegate's reasoning was based on a detailed analysis of the proposed amendments to the claims and their effect on the scope of the claims. The Delegate found that the proposed amendments were confined to the claims and that the subject matter of each of the proposed claims was identical in scope to embodiments that were present in accepted claim 12. The Delegate also found that the proposed amendments did not introduce any new terms in the claims other than the restriction of "insect cells" to the specific insect Spodoptera frugiperda Sf21 cells, which narrowed the scope of the independent claims. Therefore, the Delegate concluded that the opposition under subsection 102(2) must fail.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.